Alvogen Completes Comprehensive Refinancing - Alvogen

other

▤ Summary

MORRISTOWN, New Jersey, March 7, 2025 Alvogen Pharma US, Inc. (Alvogen or the Company), a privately owned US-based pharmaceutical company, announced the successful completion of a comprehensive refinancing of its capital structure. Alvogen raised a $553 million first lien term loan due 2028 (the First Lien Term Loan) and a $116 million second lien term loan due 2029 (the Second Lien Term Loan) to refinance its existing secured term loan due 2025, as well as to pay related fees and expenses.The First Lien Term Loan was led by funds managed by Centerbridge Partners, L.P. and Blue Torch Capital LLC.

▥ Classifications

industries
No industries detected
applications
No applications detected

◇ AskAI Classifications

Labels
No AI classifications detected

▦ Linked Companies